NAVA HEALTH MD, LLC (NAVA) Announces December 16th IPO
NAVA HEALTH MD, LLC (NAVA) Announces December 16th IPO
NAVA HEALTH MD, LLC (NAVA) is planning to raise $18 million in an initial public offering (IPO) on Friday, December 16th, IPO Scoop reports. The company will be issuing 3,000,000 shares at a price of $5.00-$7.00 per share.
IPO Scoop报道，NAVA HEALTH MD, LLC（NAVA）计划在12月16日星期五的首次公开募股（IPO）中筹集1800万美元。该公司将以每股5.00-7.00美元的价格发行3,000,000股股票。
In the last 12 months, NAVA HEALTH MD, LLC generated $9.3 million in revenue and $80,000 in net income. NAVA HEALTH MD, LLC has a market-cap of $87 million.
在过去的12个月中，NAVA HEALTH MD, LLC创造了930万美元的收入和8万美元的净收入。NAVA HEALTH MD, LLC的市值为8700万美元。
WestPark Capital served as the underwriter for the IPO.
WestPark Capital是首次公开募股的承销商。
NAVA HEALTH MD, LLC provided the following description of their company for its IPO: " Nava is a vertically integrated tech-enabled healthcare practice combining traditional, functional, holistic and regenerative medicine. (Incorporated in Delaware) Our innovative medical practice uses a data-driven personalized approach to optimize health and increase longevity. We provide each client with an individualized wellness roadmap tailored to their specific symptoms, medical needs and personal goals, which we refer to as their "Custom Vitality Plan" or "CVP." The client's CVP is developed as part of our proprietary diagnostic process, the "Nava Method," which utilizes propriety software owned and developed by Nava. We believe Nava's proprietary diagnostic process enables our practitioners to leverage various synergistic products and services for our clients. We deliver our health services through three (3) physical locations in the Baltimore/Washington Metro region. We currently plan to open up to eight (8) additional locations by the end of 2023, subject to market conditions and anticipated demand for our services. Our on-premises locations offer a premium client experience and luxurious spa-like atmosphere. Our on-premises locations provide hands-on treatment options, including, but not limited to, physician appointments and medical procedures, intravenous (IV) micronutrient therapies, massage, acupuncture and our aesthetic services such as Botox injections and body sculpting. We also provide services through telehealth, delivering on-demand healthcare via mobile devices, video or phone in Alabama, Arizona, Colorado, Delaware, Illinois, Maryland, Michigan, Minnesota, New York, Pennsylvania, Tennessee, Texas, Vermont, Virginia, Washington, D.C., and Wisconsin. Nava Medical specializes in bio-identical hormone optimization, medically supervised weight loss programs, Platelet Rich Plasma (PRP) procedures, digestive health programs, advanced diagnostic testing, IV micro-nutrient therapy, hyperbaric oxygen therapy, light therapy, intelligent bioenergetics therapy, B-12 injections, Botox injections, dermal fillers, body sculpting and a full line of premium grade nutraceuticals, supplements and skin health/ aesthetic products. Nava Medical also has a fully equipped in-office clinical laboratory that provides diagnostic testing for Nava's client, conveniently increasing the speed of research and results. Lab tests include, but are not limited to, chemistry, hematology, immunoassay, genetic, allergy, food sensitivity and other blood and urine panels. Nava has six general areas of expertise and offerings, including but not limited to Diagnostic Testing, Bio-identical Hormone Replacement Therapies (BHRT), Regenerative Therapies, Aesthetics, Functional Nutrition and premium-grade retail products. **Note: Revenue and net income figures are for the 12 months that ended June 30, 2022. (Note: Nava Health MD, LLC filed an S-1/A on Dec. 5, 2022, in which its increased the size of its IPO by adding a secondary portion – 1.02 million shares (1,022,521 shares) to be offered by the selling stockholders – to the deal's initial size of 2.0 million shares being offered by the company. The price range remained at $5.00 to $7.00. The IPO is now expected to raise a total of $18.12, but the company will still receive only $12.0 million in IPO proceeds. The company will not receive any proceeds from the sale of the selling stockholders' shares. Nava Health MD, LLC filed its S-1 on Oct. 27, 2022, and disclosed terms for its IPO – 2.0 million shares at $5.00 to $7.00 to raise $12.0 million. The company submitted confidential IPO documents on Sept. 13, 2022.) ".
NAVA HEALTH MD, LLC在首次公开募股时对其公司进行了以下描述：“Nava是一家以技术为基础的垂直整合医疗保健机构，结合了传统、功能、整体和再生医学。（在特拉华州注册成立）我们的创新医疗实践使用数据驱动的个性化方法来优化健康并延长寿命。我们为每位客户提供根据其特定症状、医疗需求和个人目标量身定制的个性化健康路线图，我们将其称为 “定制活力计划” 或 “CVP”。客户的CVP是作为我们专有诊断流程 “Nava Method” 的一部分开发的，该过程利用了Nava拥有和开发的专有软件。我们相信，Nava 的专有诊断流程使我们的从业者能够为我们的客户利用各种协同产品和服务。我们通过巴尔的摩/华盛顿地铁地区的三（3）个物理地点提供医疗服务。我们目前计划在2023年底之前再开设多达八 (8) 个地点，具体视市场状况和对我们服务的预期需求而定。我们的本地办公地点提供优质的客户体验和奢华的水疗般的氛围。我们的本地诊所提供亲身治疗选项，包括但不限于医生预约和医疗程序、静脉注射 (IV) 微量营养素疗法、按摩、针灸以及我们的美学服务，例如肉毒杆菌毒素注射和塑身。我们还通过远程医疗提供服务，通过移动设备、视频或电话在阿拉巴马州、亚利桑那州、科罗拉多州、特拉华州、伊利诺伊州、马里兰州、密歇根州、明尼苏达州、纽约州、宾夕法尼亚州、田纳西州、德克萨斯州、佛蒙特州、弗吉尼亚州、华盛顿特区和威斯康星州提供按需医疗服务。Nava Medical 专门从事生物相同激素优化、医学监督的减肥计划、富血小板血浆 (PRP) 手术、消化健康计划、高级诊断测试、静脉微量营养素疗法、高压氧疗法、光疗、智能生物能量疗法、B-12 注射、肉毒杆菌注射、皮肤填充剂、塑身以及全系列优质营养品、补品和皮肤健康/美容产品。Nava Medical 还拥有设备齐全的办公室临床实验室，可为 Nava 的客户提供诊断测试，从而方便地提高了研究和结果的速度。实验室测试包括但不限于化学、血液学、免疫分析、遗传、过敏、食物敏感性以及其他血液和尿液检测。Nava 拥有六个一般专业领域和产品，包括但不限于诊断测试、生物相同激素替代疗法 (BHRT)、再生疗法、美学、功能营养和优质零售产品。**注意：收入和净收入数据是截至2022年6月30日的12个月的数据。（注意：Nava Health MD, LLC于2022年12月5日提交了S-1/A，在该文件中，该公司在最初发行的200万股交易规模的基础上增加了二级部分——由卖出股东发行的102万股（1,022,521股），从而扩大了首次公开募股的规模。价格区间保持在5.00美元至7.00美元。现在预计首次公开募股将共筹集18.12美元，但该公司仍将仅获得1,200万美元的首次公开募股收益。公司不会从出售出售股东的股份中获得任何收益。Nava Health MD, LLC于2022年10月27日提交了S-1，并披露了首次公开募股的条款——200万股，价格为5.00美元至7.00美元，筹集了1,200万美元。该公司于2022年9月13日提交了机密的首次公开募股文件。）”。
NAVA HEALTH MD, LLC was founded in 2013 and has 90 employees. The company is located at 9755 Patuxent Woods Drive Suite 100 Columbia, MD 21046 and can be reached via phone at (410) 910-6156 or on the web at
NAVA HEALTH MD, LLC 成立于 2013 年，拥有 90 名员工。该公司位于 9755 Patuxent Woods Drive Suite 100 马里兰州哥伦比亚 21046，可通过电话 (410) 910-6156 或在网上联系我们
Receive News & Ratings for NAVA HEALTH MD LLC Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for NAVA HEALTH MD LLC and related companies with MarketBeat.com's FREE daily email newsletter.
每天接收 NAVA HEALTH MD LLC 的新闻和评级 -在下面输入您的电子邮件地址，通过Marketbeat.com的免费每日电子邮件时事通讯接收NAVA HEALTH MD LLC及相关公司的最新新闻和分析师评级的简明每日摘要。
译文内容由第三方软件翻译。